ArticlePNAS nexus2022

Genomic screening reveals ubiquitin-like modifier activating enzyme 1 as a potent and druggable target in c-MYC-high triple negative breast cancer models.

Sheeba Jacob et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.